Preventive Maintenance Therapy on Peri-implant Diseases
PIMT
Influence of Maintenance Therapy on Peri-implant Disease
1 other identifier
observational
115
1 country
1
Brief Summary
In the field of periodontics, periodontal support therapy has proven to be essential in preventing the incidence or recurrence of periodontal diseases. The protocol is designed according to the risk profile of a patient. For example, in the presence of the history of periodontal therapy, subgingival microbiota containing large numbers of spirochetes and mobile rods can recolonize pockets 4-8 weeks after scaling. Similarly, routine maintenance of dental implants has been recommended to prudently avoid peri-implant inflammation, Indeed, the understanding of the nature of the tissue around the implant and its pattern of disease would be important to consider, even surpassing importance. Recently, a systematic review by our group has identified the importance of maintenance therapy around implants because it can help prevent about 3 times patient-level frequency peri-implantitis. Henceforth, our primary goal was to study the influence in a cross-sectional study of the frequency of peri-implantitis patients according to their post-implant placement and corresponding prosthesis visits supportive peri-implant maintenance. As such, it will be shown:
- 1.What are the local and systemic factors affecting the appearance of peri-implantitis
- 2.The ideal frequency of supportive peri-implant maintenance in patients who do not develop peri-implant disease
- 3.What is the population of patients who come to supportive peri-implant maintenance after placement of dental implants
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 23, 2016
CompletedFirst Posted
Study publicly available on registry
June 3, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedApril 25, 2017
April 1, 2017
8 months
May 23, 2016
April 24, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of peri-implantitis
* 'Peri-implant health' - Absence of bleeding or inflammation * 'Peri-implant mucositis' - Presence of bleeding (inflammation) but without bone loss * 'Peri-implantitis' - Lost of radiographic bone from the implant neck * Early:\> 4 mm probing depth; \<25% radiographic bone loss * Moderate:\> 6mm probing depth; \<50% radiographic bone loss * Severe:\> 8 mm probing depth; \> 50% radiographic bone loss
12 months
Secondary Outcomes (2)
Compliance of patients
12 months
Local and systemic factors on peri-implantitis
12 months
Study Arms (2)
Peri-implantitis
Peri-implantitis' - Loss radiographic bone beyond the biological bone remodeling at baseline (after prosthesis delivery) from the implant neck * Early:\> 4 mm probing depth; \<25% radiographic bone loss * Moderate:\> 6mm probing depth; \<50% radiographic bone loss * Severa:\> 8 mm probing depth; \> 50% radiographic bone loss
Healthy
No signs of inflammation and otherwise no bone loss beyond the biological bone remodeling
Interventions
Clinical and radiographic examination in the routine based protocol
Eligibility Criteria
Cross-sectional analysis that will include patients with dental implants (\> 250) with at least 36 months depending upon placement of the prosthesis. This procedure is justified because of the high frequency of peri-implant disease (30%) and since there is no predictable and effective treatment, only prevention can improve the success rate and functionality.
You may qualify if:
- Patients between 18 and 80 years old
- Consecutive patients that received dental implants in the last 36 months
- Patients with partial edentulism
- No antibiotic in the last 2 months
- Non-smoking or smoking \<10 cigarettes a day
You may not qualify if:
- Uncontrolled systemic diseases
- Implants because prosthetic characteristics can not be registered probing depth or attachment level appropriately
- Smoking\> 10 cigarettes a day
- Pregnant patients
- Implants not placed in our center
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Florencio Monje Gil
Badajoz, 06001, Spain
Related Publications (2)
Monje A, Aranda L, Diaz KT, Alarcon MA, Bagramian RA, Wang HL, Catena A. Impact of Maintenance Therapy for the Prevention of Peri-implant Diseases: A Systematic Review and Meta-analysis. J Dent Res. 2016 Apr;95(4):372-9. doi: 10.1177/0022034515622432. Epub 2015 Dec 23.
PMID: 26701350RESULTMonje A, Wang HL, Nart J. Association of Preventive Maintenance Therapy Compliance and Peri-Implant Diseases: A Cross-Sectional Study. J Periodontol. 2017 Oct;88(10):1030-1041. doi: 10.1902/jop.2017.170135. Epub 2017 May 26.
PMID: 28548886DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- DDS
Study Record Dates
First Submitted
May 23, 2016
First Posted
June 3, 2016
Study Start
May 1, 2016
Primary Completion
January 1, 2017
Study Completion
March 1, 2017
Last Updated
April 25, 2017
Record last verified: 2017-04